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Christine M Bassis1*, Alice L Tang2, Vincent B Young1 and Melissa A Pynnonen3Abstract
Background: The microbiota of the nares has been widely studied. However, relatively few studies have
investigated the microbiota of the nasal cavity posterior to the nares. This distinct environment has the potential to
contain a distinct microbiota and play an important role in health.
Results: We obtained 35,142 high-quality bacterial 16S rRNA-encoding gene sequence reads from the nasal cavity
and oral cavity (the dorsum of the tongue and the buccal mucosa) of 12 healthy adult humans and deposited these
data in the Sequence Read Archive (SRA) of the National Center for Biotechnology Information (NCBI) (Bioproject:
PRJNA248297). In our initial analysis, we compared the bacterial communities of the nasal cavity and the oral cavity
from ten of these subjects. The nasal cavity bacterial communities were dominated by Actinobacteria, Firmicutes,
and Proteobacteria and were statistically distinct from those on the tongue and buccal mucosa. For example, the
same Staphylococcaceae operational taxonomic unit (OTU) was present in all of the nasal cavity samples, comprising
up to 55% of the community, but Staphylococcaceae was comparatively uncommon in the oral cavity.
Conclusions: There are clear differences between nasal cavity microbiota and oral cavity microbiota in healthy adults.
This study expands our knowledge of the nasal cavity microbiota and the relationship between the microbiota of the
nasal and oral cavities.
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Bacterial communities play important roles in the health
of their hosts, including roles in immune system devel-
opment [1], nutrition [2], and resistance to infection [3].
In this study, we compared the nasal cavity microbiota
and the oral cavity microbiota from healthy adult
humans. Until recently, the bacterial community of the
healthy human nasal cavity had not been characterized
by culture-independent methods [4,5]. However, many
studies have characterized the microbiota of the healthy
human nares [6-11], which are adjacent and anterior to
the nasal cavity. Staphylococcus aureus carriage in the
nares is linked to increased risk of S. aureus infection in
other body sites [12,13]. Further, antagonism by and
competition with other members of the nares microbiota
seem to influence S. aureus nares carriage [12]. Al-
though adjacent to the nares, the nasal cavity is distinct
from the nares with a different type of epithelium, a* Correspondence: cbassis@umich.edu
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unless otherwise stated.non-keratinized stratified squamous epithelium that
transitions to a typical respiratory epithelium—ciliated
pseudostratified columnar epithelial cells and mucus-
producing goblet cells [14]. In contrast, the nares have a
keratinized, stratified squamous epithelium with hairs
and sebaceous glands. Relatively few studies have investi-
gated the bacterial community composition of the nasal
cavity in healthy humans. In this study, we sought to ex-
pand our knowledge of the healthy human nasal cavity
microbiota and compare the nasal cavity microbiota to
the oral cavity microbiota in the same subjects.Methods
Subject recruitment and characteristics
This study was approved by the University of Michigan
Institutional Review Board. All subjects provided written
informed consent. Twelve adults patients were recruited
from a tertiary care otolaryngology clinic (Additional file 1:
Table S1). Exclusion criteria were patients who had acute
or chronic sinusitis and patients who were taking antibi-
otics or oral steroids for any reason.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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4N6 DNA flocked swabs (Cat. No. 3520CA, Copan
Diagnostics Inc., Murrieta, CA, USA) were used to sam-
ple all sites. The nasal cavity was sampled by inserting
the swab into the nasal passage between the septum and
middle turbinate, taking care to avoid contact to the
nares. The dorsum of the tongue and buccal mucosa
were sampled with separate swabs. The samples were
transferred directly into the Eppendorf tubes provided
with the swab and stored on ice and then at −20°C until
DNA isolation.
DNA isolation
DNA was isolated from the swabs with a PowerSoil DNA
isolation kit (Mo Bio Laboratories, Inc., Carlsbad, CA,
USA) according to the manufacturer's instructions except
that 2 min of bead beating using the ‘Homogenize’ setting
of a Mini-BeadBeater-8 (Biospec Products, Bartlesville,
OK, USA) was done in place of 10 min of vortexing.
Primary PCR amplification, pooling, and sequencing
We based our protocol for amplifying and preparing li-
braries of the V5V3 region of the 16S rRNA-encoding
gene on HMP 16S Protocol Version 4.2 (http://www.
hmpdacc.org/doc/16S_Sequencing_SOP_4.2.2.pdf ). Each
20 μl polymerase chain reaction (PCR) reaction contained
2 μl AccuPrime PCR Buffer II (Invitrogen, Carlsbad, CA,
USA), 0.15 μl AccuPrime Taq DNA Polymerase High
Fidelity (Invitrogen), 0.2 μM primer A (CCATCTCATCC
CTGCGTGTCTCCGACTCAGXXXXXCCGTCAATTCM
TTTRAGT), 0.2 μM primer B (CCTATCCCCTGTGTG
CCTTGGCAGTCTCAGCCTACGGGAGGCAGCAG),
and 1 μl DNA for the oral cavity samples or 15.45 μl DNA
for the nasal samples. The bold portions of primer A and
primer B are 926R and 357 F, respectively. The region of
primer A represented by XXXXX is the 5–10 nucleotide
barcode sequence. The remainder of primer A and primer
B are the A adapter sequence and the B adapter sequence,
respectively, required for emPCR and 454 sequencing.
The PCR was run for 2 min at 95°C followed by 30 cycles
of 95°C for 20 s, 50°C for 30 s, and 72°C for 5 min. The
PCR products were purified with AMPure XP (Agencourt
Bioscience Corporation, Beckman Coulter, Inc., Beverly,
MA, USA) according to the manufacturer's instructions
except 0.6× the amplicon volume (10.8 μl) of beads was
used rather than 1.2× in order to remove more of the
small products. The purified PCR products were quanti-
fied with a Quant-iT PicoGreen dsDNA kit (Invitrogen)
according to the manufacturer's instructions and com-
bined into a pool with equal amounts of each amplicon.
The pool was then purified with AMPure XP (Agencourt
Bioscience Corporation) according to the manufacturer's
instructions except the volume of beads was 0.6× the
pool volume. The pool was quantified with a LibraryQuantification Kit for Roche 454 GS Titanium (Kapa
Biosystems, Inc., Wilmington, MA, USA). A Junior
emPCR (454 Life Sciences, Roche, Branford, CT, USA)
was performed, and 454 sequencing was done on a GS
Junior (454 Life Sciences) according to manufacturer's
instructions.Sequence processing
Sequences were processed with mothur v.1.28.0 according
to the Schloss SOP of November 27, 2012 [15,16]. In sum-
mary, the sff file was input to sffinfo, trim.flows was run
allowing 1 mismatch in the barcode and 2 mismatches in
the 926R region of the primer, and sequencing error was
reduced with shhh.flows. With trim.seqs, barcode and pri-
mer sequences were removed and all sequences less than
200 bases or with homopolymers longer than eight nucleo-
tides were discarded. The sequences were aligned to the
Silva reference alignment [17,18]. In order to compare se-
quences over the same region of the alignment, we set the
end position at 27659 and chose a start position that was
met by 95% of the sequences. With pre.cluster, sequences
within two base pairs were merged. Chimeras were identi-
fied with chimera.uchime [19] and removed. The se-
quences were classified using a modified form of RDP
training set version 9 (trainset9_032012.pds.tax and train-
set9_032012.pds.fasta) [20]. Sequences classified as Chloro-
plast, Mitochondria, Archaea, Eukaryota, or unknown
kingdom were removed.Sequence analysis
For our initial analysis, we included subjects only if se-
quences were obtained for a complete set of samples
(buccal mucosa, tongue, and nasal cavity). Therefore, in
order to maximize the number of subjects included in
the study, we decided to subsample 269 sequences from
each sample. So, subjects were included in our initial
analysis only if at least 269 sequences were obtained
from all three sites (nasal cavity, buccal mucosa, and
dorsal side of tongue). A distance matrix made with dist.
seqs was used with the average neighbor algorithm to
group sequences into operational taxonomic units
(OTUs) with the cluster command. OTUs defined as 3%
different were used for further analysis. The make.shared
command was used to produce a table (shared file) of
the number of sequence reads assigned to each OTU in
each sample. The shared file was used to calculate θ
(1 − θ similarity index), a metric of community dissimi-
larity that takes the relative abundances of both shared
and non-shared OTUs into account [21]. Principle co-
ordinates analysis (PCoA) was used to visualize the θ
distance matrix, and analysis of molecular variance
(AMOVA) [22] was used to test the statistical signifi-
cance of the differences between bacterial communities
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buccal mucosa communities).
Quality assurance
To ensure that the source of bacterial sequences was not
the swab itself or the DNA isolation reagents, PCR was
performed on DNA isolated from an unused swab. To
confirm that the PCR reagents were not the source of
bacterial sequences, PCR of the no-template control was
performed. Neither of these control PCRs yielded prod-
ucts visible on a gel, indicating that there was minimal
contamination from the swab or reagents.
Initial findings
Sequences obtained
After sequence processing, we obtained a total of 35,142
high-quality bacterial 16S rRNA-encoding gene se-
quence reads from 35 buccal mucosa, tongue (dorsal
side), and nasal cavity samples from 12 subjects with a
mean of 1,115 sequences per sample (Additional file 1:
Table S1). The mean sequence length after sequence
processing was 268 bases. The number of sequences ob-
tained per sample from the buccal mucosa microbiota
ranged from 715–1,684. The number of sequences ob-
tained per sample from the tongue microbiota ranged
from 519–1,597. The number of sequences obtained per
sample from the nasal cavity microbiota ranged from 1–-0.2 0.0
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Figure 1 Principal coordinates analysis of nasal cavity, buccal mucosa
performed on a matrix of θ distances between all samples. OTUs were defi
axis 2, representing 19.3% of the variance, are displayed.1,595. The sff files from which the processed sequences
were generated were submitted to the SRA (Bioproject:
PRJNA248297) except for the sff that yielded only one
sequence (nasal cavity L) (Additional file 1: Table S1).
Nasal cavity bacterial communities were distinct from the
bacterial communities on the tongue and buccal mucosa
For our initial analysis, we subsampled 269 sequences
from each sample following sequence processing. Ten
healthy adult subjects had at least 269 sequences from
each sampling site following sequence processing (nasal
cavity, dorsum of the tongue, and buccal mucosa) and
were included in the analysis (Additional file 1: Table S1).
As illustrated by PCoA of θ dissimilarities, the bacter-
ial communities clustered based on body site, with the
nasal cavity bacterial communities more similar to
each other than to the oral cavity bacterial communi-
ties (Figure 1). Based on θ dissimilarities, the differ-
ences between the bacterial communities of the nasal
cavity and each oral cavity subsite were statistically sig-
nificant (AMOVA p value <0.001 for each compari-
son). Additionally, although the bacterial communities
of the two sites in the oral cavity were more similar to
each other than to the nasal cavity communities, based
on θ dissimilarities, the bacterial communities from
the tongue and the buccal mucosa were distinct (AMOVA
p value <0.001).0.2 0.4 0.6
 1 (29.8%)
buccal mucosa
tongue - dorsal side
nasal cavity
and tongue microbiota. Principal coordinates analysis was
ned as 3% different. Axis 1, representing 29.8% of the variance, and
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Figure 2 Bacterial community composition of the nasal cavity, buccal mucosa, and tongue. Two hundred sixty-nine sequences were
subsampled from each sample. The sequences were then classified as described in the materials and methods, and the relative abundances of
sequences classified to major taxonomic groups are displayed.
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In our study and other recent studies [4,5], the bacterial
communities of the nasal cavities were dominated by Acti-
nobacteria, Firmicutes, and in some cases, Proteobacteria
(Figure 2). Corynebacteriaceae and Propionibacteriaceae
were the most prevalent families of Actinobacteria in the
nasal cavity (Figure 2). Between subjects, the levels of
Corynebacteriaceae varied from 1.5% to 62.8%, and the
levels of Propionibacteriaceae varied from 0.4% to 42.4%
(Figure 2, Additional file 2: Table S2). Actinobacteria were
present at lower levels in the communities at both oral
cavity sites, but they were from the families Micrococ-
caceae and Actinomycetaceae. Corynebacteriaceae com-
posed over 1% of the community in only one oral cavity
sample. Propionibacteriaceae was undetectable in most
oral cavity samples, and when it was detected, it never
exceeded 1% of the community.
Another striking difference between the nasal cavity and
oral cavity communities was the composition of the Firmi-
cutes. The same Staphylococcaceae OTU was present in
the nasal cavity samples of all subjects, ranging from 2.2%–
55.0% of the community, while Staphylococcaceae were not
detected in the oral cavity communities (Additional file 2:
Table S2). It was not possible to distinguish Staphylococcus
aureus and Staphylococcus epidermidis in the region of the
16S rRNA gene covered by our sequences. Generally, in the
oral cavity, Streptococcaceae was the most abundant Firmi-
cutes family, and in several subjects, the most abundant
family overall. Veillonellaceae was also more abundant in
the oral cavity.
The overall levels of Betaproteobacteria were not signifi-
cantly different between nasal cavity communities and oral
cavity communities (Kruskal-Wallis test, p value = 0.4557).
However, the composition of the Betaproteobacteria dif-
fered between the nasal cavity and the oral cavity: all threesites included Neisseriaceae at levels that were not statisti-
cally different (Kruskal-Wallis test, p value = 0.4543), but
the nasal cavity contained higher levels of Comamonada-
ceae (Kruskal-Wallis test, p value = 0.0002) and Burkhol-
deriales incertae sedis (Kruskal-Wallis test, p value =
0.0004).
Future directions
With its proximity to the sinuses—the maxillary sinuses
communicate with the nasal cavity through 1 to 2-mm
ostia—the nasal cavity microbiota might be a useful
proxy for the less accessible sinus microbiota. Signatures
of sinusitis in the sinus microbiota have recently been
identified [23]. To determine if specific changes in the
nasal cavity microbiota also accompany sinusitis and
could be used as an indicator of sinus infections, it will
be necessary to sample both the nasal cavity and the
sinus in the same subjects with and without sinusitis.
Availability of supporting data
The sff files have been deposited in the SRA (Bioproject:
PRJNA248297).
Additional files
Additional file 1: Table S1. Number of sequences obtained from each
sample and subject characteristics.
Additional file 2: Table S2. Relative abundances of bacterial families in
each sample based on classification of 16S rRNA-encoding gene sequence
reads.
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